- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bronchopulmonary Dysplasia (BPD) in China
Total 257 results
-
Sichuan Cancer Hospital and Research InstituteCompletedHigh-Grade Squamous Intraepithelial LesionsChina
-
Sichuan Cancer Hospital and Research InstituteNot yet recruitingIntrahepatic Cholangiocarcinoma | Apatinib | PD-1 Antibody | Transarterial ChemoembolizationChina
-
Sun Yat-sen UniversityRecruitingPD-1 Inhibitor | Granulocyte Colony-Stimulating FactorChina
-
Lei LiRecruitingMicrosatellite Instability | Recurrent Cervical Cancer | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
The Cleveland ClinicNational Cancer Institute (NCI); University of Southern California; Medical College... and other collaboratorsActive, not recruitingCervical Intraepithelial NeoplasiaChina, El Salvador
-
Air Force Military Medical University, ChinaRecruiting
-
Chinese PLA General HospitalCompletedDyspepsia | Gastroesophageal Reflux Disease | Bile RefluxChina
-
Beijing Institute of Heart, Lung and Blood Vessel...Beijing Anzhen Hospital; Chinese Academy of Medical Sciences, Fuwai HospitalUnknownDilated Cardiomyopathy | Hypertrophic Cardiomyopathy | Arrhythmogenic Right Ventricular Cardiomyopathy | Restrictive Cardiomyopathy | Left Ventricular Non-compactionChina
-
Newish Technology (Beijing) Co., Ltd.RecruitingHigh-grade Squamous Intraepithelial Lesion (HSIL)China
-
Beijing Institute of Heart, Lung and Blood Vessel...UnknownDilated Cardiomyopathy | Hypertrophic Cardiomyopathy | Arrhythmogenic Right Ventricular Cardiomyopathy | Restrictive Cardiomyopathy | Left Ventricular Non-compactionChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Beijing Friendship HospitalCompletedCamrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.Biliary Tract Cancer | Capecitabine | Targeted Molecular Therapy | Anti-PD-1 TherapyChina
-
Fudan UniversityNot yet recruitingGastric Cancer | MSI-H | Adjuvant Therapy | PD-1 ImmunotherapyChina
-
Shanghai Zhongshan HospitalActive, not recruitingBiliary Tract Cancer | PD-1 Antibody | Lenvatinib | GemoxChina
-
Chinese PLA General HospitalRecruitingHodgkin Lymphoma | Anti-PD-1 Antibody ResistantChina
-
Qilu Hospital of Shandong UniversityShandong UniversityRecruiting
-
RenJi HospitalRecruitingDyspepsia | Functional Gastrointestinal Disorders | Antidepressant Drug Adverse Reaction | Antidepressant Discontinuation SyndromeChina
-
Xiamen UniversityXiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...Active, not recruitingCervical Cancer | Cervical Intraepithelial Neoplasia | Condylomata AcuminataChina
-
Sichuan UniversityRecruitingNSCLC | PD-1 Inhibitor | Leptomeningeal Metastasis | Low Dose RadiotherapyChina
-
The Third Affiliated hospital of Zhejiang Chinese...RecruitingStroke | DysphagiaChina
-
The Third Affiliated hospital of Zhejiang Chinese...Recruiting
-
Shandong Cancer Hospital and InstituteRecruitingEsophageal Cancer | Epigallocatechin Gallate | Dysphagia, EsophagealChina
-
Peking Union Medical College HospitalRecruitingHepatocellular Carcinoma | PD-1 Inhibitor | RegorafenibChina
-
RenJi HospitalRecruitingUrothelial Carcinoma Bladder | PD-1 InhibitorChina
-
Fudan UniversityRecruitingCarcinosarcoma | Sarcomatoid Carcinoma | PD-1 Immunotherapy | VEGFR-TKIChina
-
Merck Sharp & Dohme LLCCompletedPrevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in SituChina
-
Zeng ChanghaoThe First Affiliated Hospital of Zhengzhou UniversityWithdrawnStroke | Cognitive Impairment | DysphagiaChina
-
Chinese PLA General HospitalRecruitingPD-1 Inhibitor Failed Patients With Classical Hodgkin LymphomaChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Affiliated Cancer Hospital... and other collaboratorsRecruiting
-
Shanghai Cancer Hospital, ChinaUnknownLung Cancer Stage IV,EGFR-mutant,TKI,PD-L1,SBRTChina
-
The Cleveland ClinicNational Cancer Institute (NCI); University of Southern California; Medical College... and other collaboratorsActive, not recruitingCervical Intraepithelial NeoplasiaColombia, China, El Salvador
-
Peking University Cancer Hospital & InstituteRecruitingMelanoma | Lung Cancer | PD-L1 | PET/CTChina
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer | Solid Tumors | Programmed Cell Death-1 (PD1, PD-1) | Programmed Cell Death 1 Ligand 1(PDL1, PD-L1) | Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)Japan
-
MuhammadCompleted
-
Lei LiRecruitingEpithelial Ovarian Cancer | Microsatellite Instability | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
Sun Yat-sen UniversityRecruitingHepatocellular Carcinoma | PD-1 Inhibitor | Lenvatinib | Hepatic Arterial Infusion ChemotherapyChina
-
Beijing Tiantan HospitalRecruitingPD - Parkinson's DiseaseChina
-
Beijing Tiantan HospitalRecruitingPD - Parkinson's DiseaseChina
-
Sun Yat-sen UniversityRecruitingImmunotherapy | DMMR Colorectal Cancer | Anti PD-1China
-
Peking Union Medical College HospitalRecruitingAnlotinib | Anti-PD-1 Antibody | Advanced Pancreatic CancerChina
-
RedHill Biopharma LimitedCompletedDyspepsia | Helicobacter Pylori InfectionUnited States
-
Peking University Third HospitalCompletedPancreatic Cancer | Stereotactic Body Radiotherapy | PD-1 InhibitorsChina
-
The Affiliated Hospital of Qingdao UniversityUnknownNSCLC Stage IV | PD-1 | ARID1AChina
-
First People's Hospital of HangzhouHangzhou Cancer HospitalRecruitingStereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLCChina
-
Zhejiang Cancer HospitalNot yet recruitingGastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and SurgeryChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityFirst Affiliated Hospital of Jinan University; Shenzhen University General...RecruitingCarcinoma | Digestive System Neoplasms | Intrahepatic Cholangiocarcinoma | First-line Treatment | PD-1 InhibitorChina
-
Zeng ChanghaoPeking University Sixth Hospital; Mianyang Central HospitalTerminatedNasopharyngeal Carcinoma | DysphagiaChina
-
Lei LiCompletedChemotherapy | Recurrent Cervical Carcinoma | Immunotherapy | Anti-PD-1 Antibody | Persistent Advanced Cervical CarcinomaChina
-
Guangdong Provincial People's HospitalRecruitingLaryngeal Cancer | DysphagiaChina
-
Zeng ChanghaoTerminatedDysphagia | Stellate Ganglion BlockChina